Sanofi Consumer Healthcare India Ltd - 544250 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanofi SA & PAC Sanofi Consumer Healthcare India Ltd - 544250 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanofi SA & PAC Sanofi Consumer Healthcare India Ltd - 544250 - Results-Financial Results For Quarter And Half Year Ended June 30 2024
Kindly refer the enclosed file for results Sanofi Consumer Healthcare lists on BSE, NSE
SCHIL's demerger from Sanofi India, sanctioned by the Mumbai bench of the National Company Law Tribunal, became effective on June 1, 2024 Sanofi Consumer Healthcare India Ltd - 544250 - Listing of Equity Shares of Sanofi Consumer Healthcare India Ltd
Trading Members of the Exchange are hereby informed that effective from September 13, 2024, the equity shares of Sanofi Consumer Healthcare India Ltd (Scrip Code: 544250) are listed and admitted to dealings on the Exchange in the list of ''T'' Group Securities. For further details please refer to the notice no. 20240911-12 dated September 11, 2024.